Honeycomb Biotechnologies

Honeycomb Biotechnologies is developing technology that can be used for single-cell analysis from basic research to pre-clinical and clinical stages. Honeycomb’s main product, HIVE CLX, enables researchers to access any cell, anywhere at any time. These advantages are attained as HIVE uses gentle cell isolation that avoid elevated pressures or microfluidic shear forces, the protocol is instrument-free for diverse settings and has built in storage for processing at preferred times. These advantages give Honeycomb’s technology unique potential for single-cell studies in innate immunology, infectious diseases and clinical research.

Jobs: